Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Feb 24, 2017
Financial News
Modus Therapeutics completes venture financing
...AM (Stockholm, Sweden) raised SEK32 million ($3.6 million) in a venture round with existing investors
KDev Investments
...
Read More
BioCentury
|
Mar 24, 2014
Financial News
Rosetta Capital Ltd. financial update
...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Mar 24, 2014
Finance
Rosetta (mile)stones
...Most recently, the firm paid SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Mar 20, 2014
Financial News
Rosetta Capital buys part of pharma venture portfolio
...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Mar 18, 2013
Financial News
Karolinska Development financial update
...Rosetta Capital (London, U.K.) paid SEK220 million ($34.4 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Jan 14, 2013
Finance
Rosetta's Nordic preferences
...will likely be the only such arrangement for Karolinska. Karolinska created a private holding company,
KDev Investments
...
Read More
BioCentury
|
Dec 24, 2012
Financial News
Karolinska Development, Rosetta Capital Ltd. financial update
...firm Rosetta Capital will pay SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Dec 22, 2012
Financial News
Rosetta syndicate acquiring stake in Karolinska companies
...Rosetta Capital Ltd. will pay SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
Items per page:
10
1 - 8 of 8
BioCentury
|
Feb 24, 2017
Financial News
Modus Therapeutics completes venture financing
...AM (Stockholm, Sweden) raised SEK32 million ($3.6 million) in a venture round with existing investors
KDev Investments
...
Read More
BioCentury
|
Mar 24, 2014
Financial News
Rosetta Capital Ltd. financial update
...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Mar 24, 2014
Finance
Rosetta (mile)stones
...Most recently, the firm paid SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Mar 20, 2014
Financial News
Rosetta Capital buys part of pharma venture portfolio
...recently in 2012, Rosetta paid SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Mar 18, 2013
Financial News
Karolinska Development financial update
...Rosetta Capital (London, U.K.) paid SEK220 million ($34.4 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Jan 14, 2013
Finance
Rosetta's Nordic preferences
...will likely be the only such arrangement for Karolinska. Karolinska created a private holding company,
KDev Investments
...
Read More
BioCentury
|
Dec 24, 2012
Financial News
Karolinska Development, Rosetta Capital Ltd. financial update
...firm Rosetta Capital will pay SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
BioCentury
|
Dec 22, 2012
Financial News
Rosetta syndicate acquiring stake in Karolinska companies
...Rosetta Capital Ltd. will pay SEK220 million ($33 million) to acquire a minority stake in
KDev Investments
...
Read More
Items per page:
10
1 - 8 of 8
Previous page
Next page